2nd Quarter - Amendment

BOCKORNY GROUP, INC. for GENERIC PHARMACEUTICAL ASSOCIATION

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 21, 2014 $50,000 Replaced
2nd Quarter - Amendment (this page) Jan 21, 2016 $50,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 3204, Drug Quality and Security Act H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013 S. 1413, FDA User Fee Protection Act S. 504, Fair And Immediate Release of Generic Drugs Act

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
MARTINA L. BRADFORD —
BLAIR C LARKINS —
TODD THORPE —
NICOLE VENABLE —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); White House Office; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 2725 (113th), H.R. 3204 (113th), S. 1413 (113th), S. 504 (113th)

Budget/Appropriations BUD

Ag-appropriations language related to labeling issues

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
MARTINA L. BRADFORD —
BLAIR C LARKINS —
TODD THORPE —
NICOLE VENABLE —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS)

Pharmacy PHA

S.959, Pharmaceutical Quality, Security, and Accountability Act Issues Related to Biosimilar Regulation, Labeling, E-Labeling and Access Issues Related to the newly-formed Affordable Medicine Caucus

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
MARTINA L. BRADFORD —
BLAIR C LARKINS —
TODD THORPE —
NICOLE VENABLE —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); White House Office; SENATE

Bills named: S. 959 (113th)

Copyright/Patent/Trademark CPT

Issues relating to Patent Settlements. S. 214, Preserve Access to Affordable Generics Act

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
MARTINA L. BRADFORD —
BLAIR C LARKINS —
TODD THORPE —
NICOLE VENABLE —

Contacted: Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); SENATE; White House Office; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 214 (113th)

Medicare/Medicaid MMM

Issues Relating to Medicare Part D

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
MARTINA L. BRADFORD —
BLAIR C LARKINS —
TODD THORPE —
NICOLE VENABLE —

Contacted: Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); White House Office; HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Trade (domestic/foreign) TRD

Issues Related to Ongoing Trans-Pacific Partnership (TPP) Negotiations (No Specific Legislation) Issues Related to the Renewal of Trade Promotion Authority (TPA) Issues related to Risk Evaluation and Mitigation Strategies

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
MARTINA L. BRADFORD —
BLAIR C LARKINS —
TODD THORPE —
NICOLE VENABLE —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); White House Office; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.